Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Abstracto

Vaccination in the Endemics

Matteo Brunelli

Vaccines give direct protection by making people less susceptible to sickness or infection. Following the publication of genetic sequence of SARS-CoV-2, the virus that causes COVID-19, sparked a surge in global research and development efforts to produce a vaccine to combat the disease. The enormity of the COVID-19 pandemic's humanitarian and economic effect propels the evaluation of next-generation vaccine technology platforms through novel development paradigms. It is imperative to develop various vaccine platforms and strategies in parallel as the immune responses is poorly understood and it is unclear which vaccine strategies will be most successful. A new paradigm for the development of the vaccine was suggested, which includes the development schedule from 10-15 to 1-2 years in order to address the urgent demand.